Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Prognostic value of platelet to lymphocyte ratio on cardiovascular complications in chronic hemodialysis patients this study was done to determine the prognostic value of PLR on cardiovascular complications like vascular calcifications and atherosclerosis in carotid and coronary arteries in chronic hemodialysis patients
Prognostic value of platelet to lymphocyte ratio on cardiovascular complications in chronic hemodialysis patients this study was done to determine the prognostic value of PLR on cardiovascular complications like vascular calcifications and atherosclerosis in carotid and coronary arteries as these complications are common and well-known causes of morbidity and mortality in chronic hemodialysis patients
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| disease group | 60 patients of ESKD on maintenance hemodialysis were investigated for platelet to lymphocyte ratio, S.PTH , S.Ca , S.Phosp Echocardiography and carotid duplex | ||
| Healthy control group | 20 healthy persons were investigated for platelet to lymphocyte ratio to be compared with the disease group results |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To evaluate the association between platelet-to-lymphocyte ratio and cardiovascular complications in patients on chronic maintenance hemodialysis. | Primary Outcome Association between PLR and cardiovascular complications in chronic hemodialysis patients. Secondary Outcomes optimal PLR cutoff for cardiovascular complication prediction relation of PLR to individual cardiovascular diagnoses relation of PLR to cardiovascular hospitalization relation of PLR to cardiovascular mortality | 6 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
We are going to exclude patients who have:
Not provided
Not provided
patients undergoing hemodialysis for more than 3 months
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hassan Mohammad Mohyedin, Professor of internal medicine | faculty of medicine elminya university | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kiriazy | Minya | Elminya | 2422998 | Egypt |
Not provided
| Label | URL |
|---|---|
| PLR Prognostic Value | View source |
Not provided
privacy
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Oct 8, 2023 | Apr 2, 2026 | Prot_000.pdf |
Not provided
Not provided
Not provided
Not provided